Adjunct Associate Professor

Dr Ross Norris

PhD, MAppSc, BAppSc

Medicine & Health
School of Clinical Medicine

A/Prof Ross Norris obtained his Bachelor of Applied Science (applied chemistry) in 1979 and Master of Applied Science in 1985 from the Queensland University of Technology and his PhD in Medicine from the University of Queensland in 2002. He is an analytical chemist recognised as expert in TDM, especially in the areas of drug analysis and pharmacokinetics, using physico-chemical methods of analysis (High performance liquid chromatography, mass spectrometry, etc.) since 1979. A/Prof Norris was the Chief Scientist in the Therapeutic Drug Monitoring (TDM) Laboratory in the Department of Clinical Pharmacology, Princess Alexandra Hospital in Brisbane from 1985 to 1996 and Research Consultant, Australian Centre for Paediatric Pharmacokinetics, Mater Health Services (2002 – 2014), also holding the joint position of Senior Scientist, Therapeutic Advisory Service, Mater Health Services, Brisbane from 2008 -2010. 

Ross also holds adjunct appointments as Associate Professor, St Vincent’s Clinical School, UNSW Medicine, The University of New South Wales Australia; Associate Professor, Griffith University, School of Pharmacy, Gold Coast, Qld. He chairs the Special Drugs Working Party for the Royal College of Pathologists of Australasia Quality Assurance Program and also the Standards of Practice Committee, International Association of TDM and Clinical Toxicology (IATDMCT). He has also initiated and chaired three biannual TDM meetings in Australia since 2010, and successfully led a bid to hold the international TDM congress in Sydney in 2018 which he also co-chairs.

He has published more than 60 papers, book chapters and letters to editors primarily in the area of TDM.

Phone
0410557913
Location
Advisor (Clinical Pharmacology Laboratory) Clinical Pharmacology, School of Medicine & Public Health, University of Newcastle, Newcastle, Australia, and Hunter Medical Research Institute, Lot 1, Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.
  • Book Chapters | 2011
    2011, 'Melatonin for non-respiratory sleep disorders in children with neurodevelopmental disorders', in Khan S (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009140
    Book Chapters | 2011
    2011, 'Melatonin for non-respiratory sleep disorders in typically developing children', in Khan S (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009141
    Book Chapters | 2010
    2010, 'Melatonin for non-respiratory sleep disorders in visually impaired children', in Khan S (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd008473
  • Journal articles | 2022
    2022, 'LC–MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring', Journal of Mass Spectrometry and Advances in the Clinical Lab, 26, pp. 48 - 59, http://dx.doi.org/10.1016/j.jmsacl.2022.11.001
    Journal articles | 2022
    2022, 'Mitigating analyte to stable isotope labelled internal standard cross-signal contribution in quantitative liquid chromatography-tandem mass spectrometry', Journal of Mass Spectrometry and Advances in the Clinical Lab, 24, pp. 57 - 64, http://dx.doi.org/10.1016/j.jmsacl.2022.04.002
    Journal articles | 2021
    2021, 'Correction to: An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy (European Journal of Clinical Microbiology & Infectious Diseases, (2018), 37, 11, (2171-2175), 10.1007/s10096-018-3357-9)', European Journal of Clinical Microbiology and Infectious Diseases, 40, pp. 1789, http://dx.doi.org/10.1007/s10096-021-04291-6
    Journal articles | 2021
    2021, 'Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapy', European Journal of Clinical Microbiology and Infectious Diseases, 40, pp. 1521 - 1528, http://dx.doi.org/10.1007/s10096-021-04201-w
    Journal articles | 2019
    2019, 'Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detection', Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1126-1127, http://dx.doi.org/10.1016/j.jchromb.2019.121764
    Journal articles | 2019
    2019, 'Urinary piperacillin/tazobactam pharmacokinetics in vitro to determine the pharmacodynamic breakpoint for resistant Enterobacteriaceae', International Journal of Antimicrobial Agents, 54, pp. 240 - 244, http://dx.doi.org/10.1016/j.ijantimicag.2019.05.013
    Journal articles | 2018
    Imani S; Buscher H; Day R; Gentili S; Jones GR D; Marriott D; Norris R; Sandaradura I, 2018, 'An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy', European Journal of Clinical Microbiology and Infectious Diseases, 37, pp. 2171 - 2175, http://dx.doi.org/10.1007/s10096-018-3357-9
    Journal articles | 2018
    2018, 'Enhancement and suppression of ionization in drug analysis using HPLC-MS/MS in support of therapeutic drug monitoring: A review of current knowledge of its minimization and assessment', Therapeutic Drug Monitoring, 40, pp. 1 - 8, http://dx.doi.org/10.1097/FTD.0000000000000471
    Journal articles | 2018
    2018, 'Preliminary evidence for enhanced thymine absorption: A putative new phenotype associated with fluoropyrimidine toxicity in cancer patients', Therapeutic Drug Monitoring, 40, pp. 495 - 502, http://dx.doi.org/10.1097/FTD.0000000000000532
    Journal articles | 2017
    George R; Haywood A; Good P; Hennig S; Khan S; Norris R; Hardy J, 2017, 'Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?', Clinical Therapeutics, 39, pp. 1840 - 1848, http://dx.doi.org/10.1016/j.clinthera.2017.07.044
    Journal articles | 2017
    Khan S; Heussler H; Mcguire T; Dakin C; Pache D; Cooper D; Norris R; Flenady V; Charles B, 2017, 'Melatonin for non-respiratory sleep disorders in children with neurodevelopmental disorders', Cochrane Database of Systematic Reviews, 2017, http://dx.doi.org/10.1002/14651858.CD009140.pub2
    Journal articles | 2017
    Khan S; Heussler H; Mcguire T; Dakin C; Pache D; Cooper D; Norris R; Flenady V; Charles B, 2017, 'Melatonin for non-respiratory sleep disorders in typically developing children', Cochrane Database of Systematic Reviews, 2017, http://dx.doi.org/10.1002/14651858.CD009141.pub2
    Journal articles | 2017
    Kunarajah K; Hennig S; Norris RL G; Lobb M; Charles BG; Pinkerton R; Moore AS, 2017, 'Erratum to: Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles? (Cancer Chemotherapy and Pharmacology, (2017), 80, 1, (15-25), 10.1007/s00280-017-3309-6)', Cancer Chemotherapy and Pharmacology, 80, pp. 27 - 28, http://dx.doi.org/10.1007/s00280-017-3338-1
    Journal articles | 2017
    Kunarajah K; Hennig S; Norris RL G; Lobb M; Charles BG; Pinkerton R; Moore AS, 2017, 'Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?', Cancer Chemotherapy and Pharmacology, 80, pp. 15 - 25, http://dx.doi.org/10.1007/s00280-017-3309-6
    Journal articles | 2017
    Leshinsky J; McLachlan A; Foster DJ R; Norris R; Barrs VR, 2017, 'Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats', PLoS ONE, 12, http://dx.doi.org/10.1371/journal.pone.0178783
    Journal articles | 2016
    Barras MA; Serisier D; Hennig S; Jess K; Norris RL G, 2016, 'Bayesian estimation of tobramycin exposure in patients with cystic fibrosis', Antimicrobial Agents and Chemotherapy, 60, pp. 6698 - 6702, http://dx.doi.org/10.1128/AAC.01131-16
    Journal articles | 2016
    Bista SR; Haywood A; Hardy J; Norris R; Hennig S, 2016, 'Exposure to fentanyl after transdermal patch administration for cancer pain management', Journal of Clinical Pharmacology, 56, pp. 705 - 713, http://dx.doi.org/10.1002/jcph.641
    Journal articles | 2016
    Duley JA; Ni M; Shannon C; Norris RL; Sheffield L; Harris M; Van Kuilenburg AB P; Mead S; Cameron A; Helsby N; George R; Charles BG, 2016, 'Towards a test to predict 5-fluorouracil toxicity: Pharmacokinetic data for thymine and two sequential metabolites following oral thymine administration to healthy adult males', European Journal of Pharmaceutical Sciences, 81, pp. 36 - 41, http://dx.doi.org/10.1016/j.ejps.2015.10.001
    Journal articles | 2016
    George R; Lobb M; Haywood A; Khan S; Hardy J; Good P; Hennig S; Norris R, 2016, 'Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection', Talanta, 149, pp. 142 - 148, http://dx.doi.org/10.1016/j.talanta.2015.11.044
    Journal articles | 2016
    Lindsay PJ; Bond SE; Norris R; Marriott DJ E; Miyakis S, 2016, 'Posaconazole therapeutic drug monitoring in a regional hospital setting', Therapeutic Drug Monitoring, 38, pp. 804 - 807, http://dx.doi.org/10.1097/FTD.0000000000000334
    Journal articles | 2015
    Bista SR; Hardy J; Tapuni A; Fu J; Gibbons K; Good P; Norris R; Haywood A, 2015, 'Validation of a fentanyl transdermal adhesion scoring tool for use in clinical practice', Journal of Pain and Symptom Management, 49, pp. 934 - 938, http://dx.doi.org/10.1016/j.jpainsymman.2014.09.017
    Journal articles | 2015
    Bista SR; Haywood A; Hardy J; Lobb M; Tapuni A; Norris R, 2015, 'Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoprotein', Xenobiotica, 45, pp. 207 - 212, http://dx.doi.org/10.3109/00498254.2014.971093
    Journal articles | 2015
    Bista SR; Haywood A; Norris R; Good P; Tapuni A; Lobb M; Hardy J, 2015, 'Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with Cancer', Clinical Therapeutics, 37, pp. 2468 - 2475, http://dx.doi.org/10.1016/j.clinthera.2015.09.002
    Journal articles | 2015
    Bista SR; Haywood A; Norris R; Good P; Tapuni A; Lobb M; Hardy J, 2015, 'Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with Cancer', Clinical Therapeutics, 37, pp. 2882 - 2883, http://dx.doi.org/10.1016/j.clinthera.2015.11.002
    Journal articles | 2015
    Hennig S; Norris R; Tu Q; Van Breda K; Riney K; Foster K; Lister B; Charles B, 2015, 'Population pharmacokinetics of phenytoin in critically ill children', Journal of Clinical Pharmacology, 55, pp. 355 - 364, http://dx.doi.org/10.1002/jcph.417
    Journal articles | 2015
    Lim AE; Tate JR; Clarke D; Norris RL; Morris RG; Martin JH, 2015, 'Clinical consequences of a miscalibrated digoxin immunoassay', Therapeutic Drug Monitoring, 37, pp. 104 - 109, http://dx.doi.org/10.1097/FTD.0000000000000118
    Journal articles | 2014
    Bista SR; Lobb M; Haywood A; Hardy J; Tapuni A; Norris R, 2014, 'Development, validation and application of an HPLC-MS/MS method for the determination of fentanyl and nor-fentanyl in human plasma and saliva', Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 960, pp. 27 - 33, http://dx.doi.org/10.1016/j.jchromb.2014.04.019
    Journal articles | 2014
    Charles B; Hardy J; Anderson H; Tapuni A; George R; Norris R, 2014, 'Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?', Supportive Care in Cancer, 22, pp. 325 - 330, http://dx.doi.org/10.1007/s00520-013-1973-6
    Journal articles | 2013
    Khan SA; George R; Charles BG; Taylor PJ; Heussler HS; Cooper DM; McGuire TM; Pache D; Norris RL G, 2013, 'Monitoring salivary melatonin concentrations in children with sleep disorders using liquid chromatography-tandem mass spectrometry', Therapeutic Drug Monitoring, 35, pp. 388 - 395, http://dx.doi.org/10.1097/FTD.0b013e3182885cb2
    Journal articles | 2013
    Ni M; Duley J; George R; Charles B; Shannon C; McGeary R; Norris R, 2013, 'Simultaneous determination of thymine and its sequential catabolites dihydrothymine and β-ureidoisobutyrate in human plasma and urine using liquid chromatography-tandem mass spectrometry with pharmacokinetic application', Journal of Pharmaceutical and Biomedical Analysis, 78-79, pp. 129 - 135, http://dx.doi.org/10.1016/j.jpba.2013.01.038
    Journal articles | 2012
    Hardy J; Norris R; Anderson H; O'Shea A; Charles B, 2012, 'Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?', Supportive Care in Cancer, 20, pp. 767 - 772, http://dx.doi.org/10.1007/s00520-011-1147-3
    Journal articles | 2012
    Khor KH; Campbell FE; Charles BG; Norris RL G; Greer RM; Rathbone MJ; Mills PC, 2012, 'Comparative pharmacokinetics and pharmacodynamics of tablet, suspension and paste formulations of atenolol in cats', Journal of Veterinary Pharmacology and Therapeutics, 35, pp. 437 - 445, http://dx.doi.org/10.1111/j.1365-2885.2011.01342.x
    Journal articles | 2012
    Norris RL G; Paul M; George R; Moore A; Pinkerton R; Haywood A; Charles B, 2012, 'A stable-isotope HPLC-MS/MS method to simplify storage of human whole blood samples for glutathione assay', Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 898, pp. 136 - 140, http://dx.doi.org/10.1016/j.jchromb.2012.04.003
    Journal articles | 2012
    Roberts JA; Norris R; Paterson DL; Martin JH, 2012, 'Therapeutic drug monitoring of antimicrobials', British Journal of Clinical Pharmacology, 73, pp. 27 - 36, http://dx.doi.org/10.1111/j.1365-2125.2011.04080.x
    Journal articles | 2011
    Barras M; Alraman H; Kirkpatrick CM J; Harris M; Dakin C; Jess K; Pilbeam M; Norris RL G, 2011, 'Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis', Journal of Pharmacy Practice and Research, 41, pp. 183 - 187, http://dx.doi.org/10.1002/j.2055-2335.2011.tb00857.x
    Journal articles | 2011
    Hardy J; O'Shea A; Gilbert C; Norris R, 2011, 'Is levomepromazine stable over time?', Palliative Medicine, 25, pp. 284 - 285, http://dx.doi.org/10.1177/0269216310387963
    Journal articles | 2011
    Khan S; Heussler H; McGuire T; Dakin C; Pache D; Cooper D; Norris R; Flenady V; Charles B, 2011, 'Melatonin for non-respiratory sleep disorders in visually impaired children.', Cochrane database of systematic reviews (Online)
    Journal articles | 2011
    Khan SA; Heussler H; McGuire T; Dakin C; Pache D; Norris R; Cooper D; Charles B, 2011, 'Therapeutic Options in the Management of Sleep Disorders in Visually Impaired Children: A Systematic Review', Clinical Therapeutics, 33, pp. 168 - 181, http://dx.doi.org/10.1016/j.clinthera.2011.03.002
    Journal articles | 2011
    Moore AS; Norris R; Price G; Nguyen T; Ni M; George R; Van Breda K; Duley J; Charles B; Pinkerton R, 2011, 'Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach', Journal of Paediatrics and Child Health, 47, pp. 875 - 882, http://dx.doi.org/10.1111/j.1440-1754.2011.02103.x
    Journal articles | 2010
    Jones G, 2010, 'Therapeutic Monitoring of Vancomycin in Adult Patients: A Consensus Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists', Clinical Biochemist Reviews, 31, pp. 21 - 24
    Journal articles | 2010
    2010, 'Current status of therapeutic drug monitoring in Australian and New Zealand: A need for improved assay evaulation, best practice guidelines, and professional development', Therapeutic Drug Monitoring, 32, pp. 615 - 623, http://dx.doi.org/10.1097/FTD.0b013e3181ea3e8a
    Journal articles | 2009
    Haywood A; Burrell A; Van Breda K; George R; Testa C; Norris R, 2009, 'Stability of melatonin in an extemporaneously compounded sublingual solution and hard gelatin capsule', International Journal of Pharmaceutical Compounding, 13, pp. 170 - 174
    Journal articles | 2009
    Jones T; Van Breda K; Charles B; Dean AJ; McDermott BM; Norris R, 2009, 'Determination of risperidone and 9-hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders', Biomedical Chromatography, 23, pp. 929 - 934, http://dx.doi.org/10.1002/bmc.1204
    Journal articles | 2009
    2009, 'Preliminary results of a therapeutic drug monitoring survey in Australasia', Pathology, 41, pp. 71 - 71, http://dx.doi.org/10.1097/01268031-200941001-00167
    Journal articles | 2008
    Hennig S; Norris R; Kirkpatrick CM J, 2008, 'Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis - A population pharmacokinetic study', British Journal of Clinical Pharmacology, 65, pp. 502 - 510, http://dx.doi.org/10.1111/j.1365-2125.2007.03045.x
    Journal articles | 2008
    Norris R, 2008, 'Surface contamination from cytotoxic drugs', Journal of Pharmacy Practice and Research, 38, pp. 332
    Journal articles | 2008
    2008, 'Letters to the Editor', Journal of Pharmacy Practice and Research, 38, pp. 327 - 333, http://dx.doi.org/10.1002/j.2055-2335.2008.tb00400.x
    Journal articles | 2006
    Al Za'abi MA; Dehghanzadeh GH; Norris RL G; Charles BG, 2006, 'A rapid and sensitive microscale HPLC method for the determination of indomethacin in plasma of premature neonates with patent ductus arteriousus', Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 830, pp. 364 - 367, http://dx.doi.org/10.1016/j.jchromb.2005.11.025
    Journal articles | 2006
    Anh AV Q; Norris RL G; Charles BG, 2006, 'Modelling drug loss during intravenous infusion to premature neonates', Journal of Pharmacy Practice and Research, 36, pp. 262 - 265, http://dx.doi.org/10.1002/j.2055-2335.2006.tb00626.x
    Journal articles | 2006
    Charles B; Norris R; Xiao X; Hague W, 2006, 'Population pharmacokinetics of metformin in late pregnancy', Therapeutic Drug Monitoring, 28, pp. 67 - 72, http://dx.doi.org/10.1097/01.ftd.0000184161.52573.0e
    Journal articles | 2005
    Gilbert CM; McGeary RP; Filippich LJ; Norris RL G; Charles BG, 2005, 'Simultaneous liquid chromatographic determination of doxorubicin and its major metabolite doxorubicinol in parrot plasma', Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 826, pp. 273 - 276, http://dx.doi.org/10.1016/j.jchromb.2005.08.017
    Journal articles | 2002
    Norris RL G; Seawright AA; Shaw GR; Senogles P; Eaglesham GK; Smith MJ; Chiswell RK; Moore MR, 2002, 'Hepatic xenobiotic metabolism of cylindrospermopsin in vivo in the mouse', Toxicon, 40, pp. 471 - 476, http://dx.doi.org/10.1016/S0041-0101(01)00243-4
    Journal articles | 2001
    Norris RL G; Eaglesham GK; Shaw GR; Senogles P; Chiswell RK; Smith MJ; Davis BC; Seawright AA; Moore MR, 2001, 'Extraction and purification of the zwitterions cylindrospermopsin and deoxycylindrospermopsin from Cylindrospermopsis raciborskii', Environmental Toxicology, 16, pp. 391 - 396, http://dx.doi.org/10.1002/tox.1048
    Journal articles | 2001
    Norris RL G; Seawright AA; Shaw GR; Smith MJ; Chiswell RK; Moore MR, 2001, 'Distribution of 14C cylindrospermopsin in vivo in the mouse', Environmental Toxicology, 16, pp. 498 - 505, http://dx.doi.org/10.1002/tox.10008
    Journal articles | 2001
    Norris RL; Eaglesham GK; Shaw GR; Smith MJ; Chiswell RK; Seawright AA; Moore MR, 2001, 'A sensitive and specific assay for glutathione with potential application to glutathione disulphide, using high-performance liquid chromatography-tandem mass spectrometry', Journal of Chromatography B: Biomedical Sciences and Applications, 762, pp. 17 - 23, http://dx.doi.org/10.1016/S0378-4347(01)00304-8
    Journal articles | 2000
    Senogles P; Shaw G; Smith M; Norris R; Chiswell R; Mueller J; Sadler R; Eaglesham G, 2000, 'Degradation of the cyanobacterial toxin cylindrospermopsin, from Cylindrospermopsis raciborskii, by chlorination', Toxicon, 38, pp. 1203 - 1213, http://dx.doi.org/10.1016/S0041-0101(99)00210-X
    Journal articles | 1999
    Chiswell RK; Shaw GR; Eaglesham G; Smith MJ; Norris RL; Seawright AA; Moore MR, 1999, 'Stability of cylindrospermopsin, the toxin from the cyanobacterium, cylindrospermopsis raciborskii: Effect of pH, temperature, and sunlight on decomposition', Environmental Toxicology, 14, pp. 155 - 161, http://dx.doi.org/10.1002/(SICI)1522-7278(199902)14:1<155::AID-TOX20>3.0.CO;2-Z
    Journal articles | 1999
    Eaglesham GK; Norris RL; Shaw GR; Smith MJ; Chiswell RK; Davis BC; Neville GR; Seawright AA; Moore MR, 1999, 'Use of HPLC-MS/MS to monitor cylindrospermopsin, a blue-green algal toxin, for public health purposes', Environmental Toxicology, 14, pp. 151 - 154, http://dx.doi.org/10.1002/(SICI)1522-7278(199902)14:1<151::AID-TOX19>3.0.CO;2-D
    Journal articles | 1999
    Norris RL; Eaglesham GK; Pierens G; Shaw GR; Smith MJ; Chiswell RK; Seawright AA; Moore MR, 1999, 'Deoxycylindrospermopsin, an analog of cylindrospermopsin from cylindrospermopsis raciborskii', Environmental Toxicology, 14, pp. 163 - 165, http://dx.doi.org/10.1002/(SICI)1522-7278(199902)14:1<163::AID-TOX21>3.0.CO;2-V
    Journal articles | 1999
    Seawright AA; Nolan CC; Shaw GR; Chiswell RK; Norris RL; Moore MR; Smith MJ, 1999, 'The oral toxicity for mice of the tropical cyanobacterium Cylindrospermopsis raciborskii (Woloszynska)', Environmental Toxicology, 14, pp. 135 - 142, http://dx.doi.org/10.1002/(SICI)1522-7278(199902)14:1<135::AID-TOX17>3.0.CO;2-L
    Journal articles | 1999
    Shaw GR; Sukenik A; Livne A; Chiswell RK; Smith MJ; Seawright AA; Norris RL; Eaglesham GK; Moore MR, 1999, 'Blooms of the cylindrospermopsin containing cyanobacterium, Aphanizomenon ovalisporum (Fofti), in newly constructed lakes, Queensland, Australia', Environmental Toxicology, 14, pp. 167 - 177, http://dx.doi.org/10.1002/(SICI)1522-7278(199902)14:1<167::AID-TOX22>3.0.CO;2-O
    Journal articles | 1997
    Salm P; Taylor PJ; Clark A; Balderson GA; Grygotis A; Norris RL G; Lynch SV; Shaw LM; Pond SM, 1997, 'High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants', Therapeutic Drug Monitoring, 19, pp. 694 - 700, http://dx.doi.org/10.1097/00007691-199712000-00015
    Journal articles | 1996
    Taylor PJ; Jones A; Balderson GA; Lynch SV; Norris RL G; Pond SM, 1996, 'Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry', Clinical Chemistry, 42, pp. 279 - 285, http://dx.doi.org/10.1093/clinchem/42.2.279
    Journal articles | 1995
    Dodds HM; Norris RL G; Johnson AG; Pond SM, 1995, 'Evaluation and comparison of the TDxII, stratus, and OPUS digoxin assays', Therapeutic Drug Monitoring, 17, pp. 68 - 74, http://dx.doi.org/10.1097/00007691-199502000-00011
    Journal articles | 1994
    Norris RL G; Ravenscroft PJ; Pond SM, 1994, 'Sensitive high-performance liquid chromatographic assay with ultraviolet detection of methadone enantiomers in plasma', Journal of Chromatography B: Biomedical Sciences and Applications, 661, pp. 346 - 350, http://dx.doi.org/10.1016/0378-4347(94)00341-6
    Journal articles | 1994
    Taylor PJ; Salm P; Norris RL G; Ravenscroft PJ; Pond SM, 1994, 'Comparison of high-performance liquid chromatography and monoclonal fluorescence polarization immunoassay for the determination of whole-blood cyclosporin a in liver and heart transplant patients', Therapeutic Drug Monitoring, 16, pp. 526 - 530, http://dx.doi.org/10.1097/00007691-199410000-00015
    Journal articles | 1993
    Salm P; Norris RL G; Taylor PJ; Davis DE; Ravenscroft PJ, 1993, 'A reliable high-performance liquid chromatography assay for high-throughput routine cyclosporin a monitoring in whole blood', Therapeutic Drug Monitoring, 15, pp. 65 - 69, http://dx.doi.org/10.1097/00007691-199302000-00012
    Journal articles | 1992
    Chen Y; Norris RL G; Schneider JJ; Ravenscroft PJ, 1992, 'The influence of vancomycin concentration and the pH of plasma on vancomycin protein binding', Journal of Pharmacological and Toxicological Methods, 28, pp. 57 - 60, http://dx.doi.org/10.1016/1056-8719(92)90066-A
    Journal articles | 1992
    Taylor PJ; Charles BG; Norris R; Salm P; Ravenscroft PJ, 1992, 'Measurement of dothiepin and its major metabolites in plasma by high-performance liquid chromatography', Journal of Chromatography B: Biomedical Sciences and Applications, 581, pp. 152 - 155, http://dx.doi.org/10.1016/0378-4347(92)80460-8
    Journal articles | 1989
    Norris RL G; Taylor PJ; Schneider JJ; Ravenscroft PJ; Charles BG, 1989, 'Sensitive measurement of oxazepam in plasma by high performance liquid chromatography', Journal of Drug Development, 2, pp. 109 - 113
    Journal articles | 1988
    Charles BG; Norris RL G; Ravenscroft PJ, 1988, 'A modified assay for cyclosporin in blood using solid-phase extraction with high-performance liquid chromatography', Therapeutic Drug Monitoring, 10, pp. 97 - 100, http://dx.doi.org/10.1097/00007691-198810010-00017
    Journal articles | 1988
    1988, 'A Modified Assay for Cyclosporin in Blood Using Solid-Phase Extraction with High-Performance Liquid Chromatography', Therapeutic Drug Monitoring, 10, pp. 97 - 100, http://dx.doi.org/10.1097/00007691-198801000-00017
    Journal articles | 1987
    1987, 'Temelastine does not affect theophylline pharmacokinetics in normal subjects.', Br J Clin Pharmacol, 24, pp. 673 - 675, http://dx.doi.org/10.1111/j.1365-2125.1987.tb03229.x
    Journal articles | 1986
    Norris RL G; Thomas MJ; Craswell PW, 1986, 'Assessment of a two-step high-performance liquid chromatographic assay using dual-wavelength ultraviolet monitoring for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol in human serum or plasma', Journal of Chromatography B: Biomedical Sciences and Applications, 381, pp. 53 - 61, http://dx.doi.org/10.1016/S0378-4347(00)83564-1
    Journal articles | 1984
    Cameron J; Stafford W; Pritchard D; Norris R; Ravenscroft P, 1984, 'Intravenous disopyramide in acute myocardial infarction: A haemodynamic and pharmacokinetic study', Journal of Cardiovascular Pharmacology, 6, pp. 126 - 131
    Journal articles | 1984
    Dowell PS; Pierce DM; Franklin RA; Norris R; Harries H; Whiteland H, 1984, 'The pharmacokinetics of fentiazac and its metabolite, p-hydroxyfentiazac, after twice-daily oral administration to Male volunteers', Xenobiotica, 14, pp. 947 - 953, http://dx.doi.org/10.3109/00498258409151493
    Journal articles | 1984
    Norris RL G; Ravenscroft PJ; Ahokas JT; Henry M, 1984, 'Binding of disopyramide to α1‐acid glycoprotein in plasma measured by competitive equilibrium dialysis', Journal of Pharmaceutical Sciences, 73, pp. 824 - 826, http://dx.doi.org/10.1002/jps.2600730630
    Journal articles | 1983
    Holt GW; Norris RL G; Ravenscroft PJ; Bett JH N; Dryburgh LG; Boyle CM, 1983, 'Effect of disopyramide on left ventricular performance: The relationship of free and total concentrations of the drug and of its mono-N-dealkylated metabolite to noninvasive indices of function', Journal of Cardiovascular Pharmacology, 5, pp. 51 - 54, http://dx.doi.org/10.1097/00005344-198301000-00007
    Journal articles | 1982
    Norris RL G; Ahokas JT; Ravenscroft PJ, 1982, 'Determination of unbound fraction of disopyramide in plasma: A comparison of equilibrium dialysis, ultrafiltration through dialysis membranes and ultrafree anticonvulsant drug filters', Journal of Pharmacological Methods, 7, pp. 7 - 14, http://dx.doi.org/10.1016/0160-5402(82)90053-5
    Journal articles | 1982
    Norris RL G; Ahokas JT; Ravenscroft PJ, 1982, 'Simultaneous HPLC assay of mono-N-dealkylated disopyramide, quinidine and disopyramide', Clinical and Experimental Pharmacology and Physiology, 9, pp. 452 - 453
    Journal articles | 1982
    Norris RL G; Ahokas JT; Ravenscroft PJ, 1982, 'Simultaneous high-performance liquid chromatographic assay for quinidine, disopyramide and the mono-N-dealkylated metabolite of disopyramide', Journal of Chromatography B: Biomedical Sciences and Applications, 230, pp. 433 - 437, http://dx.doi.org/10.1016/S0378-4347(00)80495-8
    Journal articles | 1981
    Norris RL G; Ahokas JT; Ravenscroft PJ, 1981, 'Determination of unbound fraction of disopyramide in plasma using a rapid ultrafiltration method', Clinical and Experimental Pharmacology and Physiology, 8
  • Preprints | 2020
    2020, Current fluconazole dosing regimens in critically ill adults result in under-exposure during early therapy, , http://dx.doi.org/10.22541/au.159769416.61783293